Citation Assignment

Peter Hirschi
References
1. Martin LW, Correa AM, Ordonez NG, et al. Sarcomatoid carcinoma of the lung: a
predictor of poor prognosis. Ann Thorac Surg. 2007;84(3):973-80.
http://dx.doi.org/10.1016/j.athoracsur.2007.03.099
2. Chi A, Liao Z, Nguyen NP, Xu J, Stea B, Komaki R. Systemic review of the patterns of
failure following stereotactic body radiation therapy in early-stage non-small-cell lung
cancer: clinical implications. Radiother Oncol. 2010;94(1):1-11.
http://dx.doi.org/10.1016/j.radonc.2009.12.008
3. Baumann P, Nyman J, Hoyer M, et al. Outcome in a prospective phase II trial of
medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic
body radiotherapy. J Clin Oncol. 2009;27(20):3290-6.
http://dx.doi.org/10.1200/JCO.2008.21.5681
4. Verbakel WF, Senan S, Cuijpers JP, Slotman BJ, Lagerwaard FJ. Rapid delivery of
stereotactic radiotherapy for peripheral lung tumors using volumetric intensity-modulated
arcs. Radiother Oncol. 2009;93(1):122-4. http://dx.doi.org/10.1016/j.radonc.2009.05.020
5. Dunlap NE, Cai J, Biedermann GB, et al. Chest wall volume receiving >30 Gy predicts
risk of severe pain and/or rib fracture after lung stereotactic body radiotherapy. Int J
Radiat Oncol Biol Phys. 2010;76(3):796-801.
http://dx.doi.org/10.1016/j.ijrobp.2009.02.027